糖筛查试验异常但口服葡萄糖耐量试验正常患者的特点:与正常及妊娠期糖尿病患者的比较

来源 :世界核心医学期刊文摘(妇产科学分册) | 被引量 : 0次 | 上传用户:yy349764474
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: The purpose of this study was to evaluate the characteristics and outcomes of patients who had abnormal glucose challenge test results and subsequent normal oral glucose tolerance test results and to assess whether such patients are at agreater risk than normal pregnant patients for adverse perinatal outcome. Study design: In this retrospective cohort study that was conducted between June and December 2003, 101 pregnant women (group A) had an abnormal glucose challenge test result and a normal oral glucose tolerance test result. Data were also collected on 2 control groups: 100 pregnant women with normal glucose challenge test results (group B) and all 76 pregnant women who were diagnosed with gestational diabetes mellitus during this period of time (group C). Patients with multiple pregnancies, chronic hypertension, pregestational diabetes mellitus, or any other maternal or fetal problems that were diagnosed before 24 weeks (when the glucose challenge test was performed) were excluded from the study groups. The following data were collected and analyzed: maternal age, maternal weight and height, parity and gravidity, diabetes mellitus in first-degree relatives, medical and obstetric history, ethnicity,complications during the third trimester of pregnancy, birth- weight, gestational age at delivery, mode of delivery, Apgar scores, cord blood gas results, maternal complications of labor and during the postpartum period, and infant admission to then eonatal intensive care unit. For comparison between groups,we used the Student t test, 1-way analysis of variance, the chis-quaretest, and stepwise logistic regression. Results: Patients in groups A and C were significantly older compared with group B (29.2 ± 5.6 years and 30.4 ± 5.5 years, respectively, vs 24.8± 5.5 years; P < .01), had a lesser rate of primiparity (48% and 31% , respectively, vs 24% ; P < .05), had greater body mass index (30.8 ± 5 kg/m2 and 31.3 ± 6 kg/m2, respectively,vs 29.2 ± 4.4 kg/m2; P < .01), had a greater rate of previous gestational diabetes mellitus (6% and 20% , respectively, vs 0% ; P < .05), and had a greater rate of first-degree family members with diabetes mellitus (21% and 21% , respectively,vs 3% ; P < .01). None of the outcome parameters was statistically significant when group A was compared with group B. Conclusion: Patients with an abnormal glucose challenge test result and a subsequent normal oral glucose tolerance test result have different maternal characteristics and backgrounds compared with patients in whom both test results are normal,yet both groups have normal outcomes. We should continue to consider patients who have an abnormal glucose challenge test result and subsequent normal oral glucose tolerance test result as low-risk; however, these findings may represent an indication of an increased likelihood for the development of overt diabetes mellitus later in life. Objective: The purpose of this study was to evaluate the characteristics and outcomes of patients who had abnormal glucose challenge test results and subsequent normal oral glucose tolerance test results and to assess whether such patients are at agreater risk than normal pregnant patients for adverse perinatal outcome. Study design: In this retrospective cohort study that was conducted between June and December 2003, 101 pregnant women (group A) had an abnormal glucose challenge test result and a normal oral glucose tolerance test result. Data were also collected on 2 control groups: 100 pregnant women with normal pregnancies in pregnancy (group B) and all 76 pregnant women who were diagnosed with gestational diabetes mellitus during this period of time (group C). Patients with multiple pregnancies, chronic hypertension, pregestational diabetes mellitus, or any other maternal or fetal problems that were diagnosed before 24 weeks (when the glucose challenge test was performed) we re excluded from the study groups. The following data were collected and analyzed: maternal age, maternal weight and height, parity and gravidity, diabetes mellitus in first-degree relatives, medical and obstetric history, ethnicity, complications during the third trimester of pregnancy, birth-weight, gestational age at delivery, mode of delivery, Apgar scores, cord blood gas results, maternal complications of labor and during the postpartum period, and infant admission to then eonatal intensive care unit. For comparison between groups, we used the Student t test, 1-way analysis of variance, the chis-quaretest, and stepwise logistic regression. Results: Patients in groups A and C were significantly older than with group B (29.2 ± 5.6 years and 30.4 ± 5.5 years, respectively, vs 24.8 ± 5.5 years; P <.01), had a lesser rate of primiparity (48% and 31%, respectively, vs 24%; P <.05), greater body mass index (30.8 ± 5 kg / m2 and 31.3 ± 6 kg / m2, respectively, vs 29.2 ± 4.4 kg / m2; P<.01), had a greater rate of first gestational diabetes mellitus (6% and 20%, respectively, vs 0%; P <.05), and had a greater rate of first-degree family members with diabetes mellitus (21% and 21%, respectively, vs 3%; P <.01). None of the outcome parameters was statistically significant when group A was compared with group B. Conclusion: Patients with an abnormal glucose challenge test result and a subsequent normal oral glucose tolerance test result have different maternal characteristics and backgrounds compared with patients in whom both both test have normal outcomes. yet should both test for patients who have an abnormal glucose challenge test result and subsequent normal oral glucose tolerance test result as low however, these findings may represent an indication of an increased likelihood for the development of overt diabetes mellitus later in life.
其他文献
茂名石化开发的聚丙烯(PP)料HP9009M新产品,近日在深圳一家大型光电元件厂试验成功,并将批量销售。这意味着该产品正式进入光电产品等高科技行业。在深圳这家光电元件厂的实
德国总理默克尔日前要求美国通用集团对通用有可能出售欧宝汽车的传言作出澄清说明。“有人称欧宝的工人是令人苦恼的包袱便要甩掉欧宝,通用必须消除这个传言所产生的影响。
以槲皮素(Qu)为模板分子、N-乙烯基吡咯烷酮(NVP)和丙烯酸(AA)为功能单体、N,N′-亚甲基双丙烯酰胺(MBA)为交联剂、Fe_3O_4纳米颗粒为磁性载体,借助表面分子印迹技术制备了能
橡塑行业中,热塑性弹性体(TPE)作为第三聚合材料,渐渐成为行业最受人瞩目的类橡胶弹性体材料。在TPE的配方中,白油作为软化剂必不可少。目前,白油主要以石油系加工油为主,但
在经济下滑期,企业往往通过削减非直接盈利的各项开支来抵抗短期利润下滑的压力,此时,化工企业的研发机构往往会难逃被削减的命运。然而,如果企业能跳出单一的成本管理思路,
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
综述了SAPO-34的合成及应用,介绍了SAPO-34的合成方法以及合成过程中的影响因素;总结了SAPO-34的应用,包括氯甲烷制烯烃,CO2加氢合成低碳烯烃,甲醇芳构化等应用。指出:结合SA
牡丹花开花落20载,20年洛阳牡丹花会,4000万 海内外游客赏花于此,220多亿资金成交于此,这张绿色的 “城市名片”已把洛阳的美名四海传扬。 20年间,牡丹花会给洛阳带来的变化
A new one-step synthesis of 3-hydroxymethylbenzofuran,based on intramolecular cyclization of 2-(methoxymethyl)-2-(20-methoxymethyl-40-methylphenyl)-butanone 1 u
患者女,38岁.反复发热6年,剖宫产术后18 d.实验室检查白细胞计数正常,转氨酶升高.超声提示肝脾增大,弥漫性肝损害.CT平扫见肝右叶及左外叶大片楔形低密度区一直延伸至肝被膜下,与正常肝组织间分界清(图1);增强后,于动脉期及门脉期未见病灶强化,但可见其中有血管结构走行(图2,3);延迟5 min后扫描,见病灶的近肝门区强化;延迟15 min后扫描,见对比剂缓慢充填病灶(图4).最后诊断:肝梗死